+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Hong Kong Wound Dressing Market Research Report: By Type, Application, End User, Distribution Channel - Industry Analysis and Revenue Estimation to 2030

  • ID: 5184631
  • Report
  • September 2021
  • Region: Hong Kong
  • 163 Pages
  • Prescient & Strategic Intelligence Private Limited

FEATURED COMPANIES

  • 3M Company
  • Cardinal Health Inc.
  • Essity AB
  • Mölnlycke Health Care AB
  • Smith & Nephew plc
  • Weigao Group Co. Ltd.
From $40.1 million in 2020, the Hong Kong wound dressing market size is projected to increase to $70.6 million by 2030, at a 6.0% CAGR between 2021 and 2030.



The major reasons behind the growing demand for products are:


Booming Geriatric Population: According to the Chinese University of Hong Kong, people aged 65 and above will make up 27% of the metropolis’ population by 2033, compared to 11.7% in 2003. Such people often injure themselves, getting nasty wounds. Additionally, they suffer from many chronic diseases that lead to wounds, thereby propelling the market growth.

Rising Diabetes Prevalence: The increasing cases of diabetes are also driving the Hong Kong wound dressing market as the disease often leads to diabetic foot ulcers, a type of chronic wound, which is hard to cure using traditional methods. A key reason behind the increasing diabetes incidence in the megacity is the rising number of obese people, as obesity is a major risk factor for this endocrine disorder.

The COVID-19 pandemic has affected the Hong Kong wound dressing market negatively as the lockdowns confined people inside their homes. This led to a major reduction in the incidence of road accidents and injuries among school and college students. In the same way, the closed surgery departments resulting in a low incidence of surgical wounds, thereby further pushing down the demand for wound dressing products.

In the coming years, the advanced bifurcation will witness the faster growth in the Hong Kong wound dressing market, within the type segment. Advanced wound dressings allow for rapid healing, temperature and moisture control around the wound, gaseous exchange, infection inhibition, and tissue regeneration.

The chronic wounds bifurcation held the larger share in the application segment of the Hong Kong wound dressing market in the past. Such wounds are long lasting and difficult to treat, which is why they require frequent changes of the dressing, preferably advanced dressing.

In the near future, the Hong Kong wound dressing market, under the end user segment, will be dominated by the hospitals & specialty clinics category. As such medical facilities employ experienced professionals and boast advanced equipment, people, especially trauma and burn victims, prefer them for getting their wounds dressed.

The pharmacies category generated the highest revenue in the Hong Kong wound dressing market historically, based on distribution channel. Being dedicated to pharma and other healthcare-related products, pharmacies offer a wide variety of traditional and advanced dressings for wounds.

Major players in the Hong Kong wound dressing market are Coloplast A/S, Paul Hartmann AG, 3M Company, Winner Medical Co. Ltd., Smith & Nephew plc, Mölnlycke Health Care AB, ConvaTec Group plc, Zhende Medical Co. Ltd., Allmed Medical Products Co. Ltd., Wayson Medical Co. Ltd., Essity AB, B. Braun Melsungen AG, Beiersdorf AG, Urgo Medical, Johnson & Johnson, Cardinal Health Inc., Integra LifeSciences Holdings Corporation, Medtronic plc, Wright Medical Group N.V., Lohmann & Rauscher GmbH & Co. KG, Medela AG, Weigao Group Co. Ltd., and Nitto Denko Corporation.
Frequently Asked Questions about the Hong Kong Wound Dressing Market

What is the estimated value of the Hong Kong Wound Dressing Market?

The Hong Kong Wound Dressing Market was estimated to be valued at $40.1 Million in 2020.

What is the growth rate of the Hong Kong Wound Dressing Market?

The growth rate of the Hong Kong Wound Dressing Market is 5.8%, with an estimated value of $70.6 Million by 2030.

What is the forecasted size of the Hong Kong Wound Dressing Market?

The Hong Kong Wound Dressing Market is estimated to be worth $70.6 Million by 2030.

Who are the key companies in the Hong Kong Wound Dressing Market?

Key companies in the Hong Kong Wound Dressing Market include Coloplast A/S, 3M Company, Paul Hartmann AG, Winner Medical Co. Ltd., Mölnlycke Health Care AB, Smith & Nephew plc, ConvaTec Group plc, Allmed Medical Products Co. Ltd. and Wayson Medical Co. Ltd..
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 3M Company
  • Cardinal Health Inc.
  • Essity AB
  • Mölnlycke Health Care AB
  • Smith & Nephew plc
  • Weigao Group Co. Ltd.

Chapter 1. Research Background
1.1 Research Objectives
1.2 Market Definition
1.3 Research Scope
1.3.1 Market Segmentation by Type
1.3.2 Market Segmentation by Application
1.3.3 Market Segmentation by End User
1.3.4 Market Segmentation by Distribution Channel
1.3.5 Analysis Period
1.3.6 Market Data Reporting Unit
1.3.6.1 Value
1.4 Key Stakeholders
Chapter 2. Research Methodology
2.1 Secondary Research
2.1.1 Paid
2.1.2 Unpaid
2.1.3 Publisher Database
2.2 Primary Research
2.2.1 Breakdown of Primary Research, by Industry Participant
2.2.2 Breakdown of Primary Research, by Designation
2.2.3 Breakdown of Primary Research, by Company Type
2.3 Market Size Estimation
2.4 Data Triangulation
2.5 Assumptions for the Study
Chapter 3. Executive Summary
Chapter 4. Introduction
4.1 Market Definition
4.1.1 By Type
4.1.1.1 Advanced
4.1.1.1.1 Foam
4.1.1.1.2 Hydrocolloid
4.1.1.1.3 Film
4.1.1.1.4 Alginate
4.1.1.1.5 Antimicrobial
4.1.1.1.6 Hydrogel
4.1.1.1.7 Collagen
4.1.1.1.8 Hydrofiber
4.1.1.1.9 Wound contact layer
4.1.1.1.10 Superabsorbent
4.1.1.1.11 NPWT
4.1.1.1.12 Others
4.1.1.2 Traditional
4.1.1.2.1 Bandages
4.1.1.2.2 Gauzes
4.1.1.2.3 Sponges
4.1.1.2.4 Abdominal pads
4.1.1.2.5 Others
4.1.2 By Application
4.1.2.1 Chronic wounds
4.1.2.1.1 DFUs
4.1.2.1.2 VLUs
4.1.2.1.3 Pressure ulcers
4.1.2.1.4 Others
4.1.2.2 Acute wounds
4.1.2.2.1 Surgical and traumatic wounds
4.1.2.2.2 Burns
4.1.3 By End User
4.1.3.1 Hospitals and specialty clinics
4.1.3.1.1 Inpatient settings
4.1.3.1.2 Outpatient settings
4.1.3.2 Homecare settings
4.1.3.3 Long-term-care settings
4.1.4 By Distribution Channel
4.1.4.1 Pharmacies
4.1.4.2 Online channels
4.2 Market Dynamics
4.2.1 Trends
4.2.1.1 Shift in consumer preference from traditional products to advanced therapies
4.2.2 Drivers
4.2.2.1 Growing geriatric population
4.2.2.2 Increasing prevalence of diabetes
4.2.2.3 High incidence of traumatic injuries
4.2.2.4 Impact analysis of drivers on market forecast
4.2.3 Restraints
4.2.3.1 High cost of advanced wound dressing products
4.2.3.2 Impact analysis of restraints on market forecast
4.2.4 Opportunities
4.2.4.1 Improving economy and increasing health expenditure
4.2.4.2 Ineffectiveness of traditional wound dressings in acute wound management
4.3 Impact of COVID-19
4.4 Porter’s Five Forces Analysis
4.5 Regulatory Overview
4.6 Wound Dressing Product Pricing
Chapter 5. Hong Kong Market Size and Forecast
5.1 By Type
5.1.1 Advanced Wound Dressing Market, by Type
5.1.1.1 Foam dressing market
5.1.1.1.1 By hospital type
5.1.1.1.2 By prescription mode
5.1.1.2 Hydrocolloid dressing market
5.1.1.2.1 By hospital type
5.1.1.2.2 By prescription mode
5.1.1.3 Film dressing market
5.1.1.3.1 By hospital type
5.1.1.3.2 By prescription mode
5.1.1.4 Alginate dressing market
5.1.1.4.1 By hospital type
5.1.1.4.2 By prescription mode
5.1.1.5 Antimicrobial dressing market
5.1.1.5.1 By hospital type
5.1.1.5.2 By prescription mode
5.1.1.6 Hydrogel dressing market
5.1.1.6.1 By hospital type
5.1.1.6.2 By prescription mode
5.1.1.7 Collagen dressing market
5.1.1.7.1 By hospital type
5.1.1.7.2 By prescription mode
5.1.1.8 Hydrofiber dressing market
5.1.1.8.1 By hospital type
5.1.1.8.2 By prescription mode
5.1.1.9 Wound contact layer dressing market
5.1.1.9.1 By hospital type
5.1.1.9.2 By prescription mode
5.1.1.10 Superabsorbent dressing market
5.1.1.10.1 By hospital type
5.1.1.10.2 By prescription mode
5.1.1.11 NPWT dressing market
5.1.1.11.1 By hospital type
5.1.1.11.2 By prescription mode
5.1.2 Traditional Wound Dressing Market, by Type
5.2 By Application
5.2.1 Wound Dressing Market for Chronic Wounds, by Type
5.2.2 Wound Dressing Market for Acute Wounds, by Type
5.3 By End User
5.3.1 Wound Dressings for Hospital and Specialty Clinic Use, by Type
5.4 By Distribution Channel
Chapter 6. Strategic Developments by Key Players
6.1 Mergers and Acquisitions
6.2 Partnerships
6.3 Other Developments
Chapter 7. Company Profiles
7.1 Coloplast A/S
7.1.1 Business Overview
7.1.2 Product and Service Offerings
7.1.3 Key Financial Summary
7.2 3M Company
7.2.1 Business Overview
7.2.2 Product and Service Offerings
7.2.3 Key Financial Summary
7.3 Paul Hartmann AG
7.3.1 Business Overview
7.3.2 Product and Service Offerings
7.3.3 Key Financial Summary
7.4 Winner Medical Co. Ltd.
7.4.1 Business Overview
7.4.2 Product and Service Offerings
7.5 Mölnlycke Health Care AB
7.5.1 Business Overview
7.5.2 Product and Service Offerings
7.5.3 Key Financial Summary
7.6 Smith & Nephew plc
7.6.1 Business Overview
7.6.2 Product and Service Offerings
7.6.3 Key Financial Summary
7.7 ConvaTec Group plc
7.7.1 Business Overview
7.7.2 Product and Service Offerings
7.7.3 Key Financial Summary
7.8 Allmed Medical Products Co. Ltd.
7.8.1 Business Overview
7.8.2 Product and Service Offerings
7.9 Zhende Medical Co. Ltd.
7.9.1 Business Overview
7.9.2 Product and Service Offerings
7.10 Wayson Medical Co. Ltd.
7.10.1 Business Overview
7.10.2 Product and Service Offerings
7.11 B. Braun Melsungen AG
7.11.1 Business Overview
7.11.2 Product and Service Offerings
7.11.3 Key Financial Summary
7.12 Essity AB
7.12.1 Business Overview
7.12.2 Product and Service Offerings
7.12.3 Key Financial Summary
7.13 Beiersdorf AG
7.13.1 Business Overview
7.13.2 Product and Service Offerings
7.13.3 Key Financial Summary
7.14 Johnson & Johnson
7.14.1 Business Overview
7.14.2 Product and Service Offerings
7.14.3 Key Financial Summary
7.15 Urgo Medical
7.15.1 Business Overview
7.15.2 Product and Service Offerings
7.16 Cardinal Health Inc.
7.16.1 Business Overview
7.16.2 Product and Service Offerings
7.16.3 Key Financial Summary
7.17 Medtronic plc
7.17.1 Business Overview
7.17.2 Product and Service Offerings
7.17.3 Key Financial Summary
7.18 Integra LifeSciences Holdings Corporation
7.18.1 Business Overview
7.18.2 Product and Service Offerings
7.18.3 Key Financial Summary
7.19 Wright Medical Group N.V.
7.19.1 Business Overview
7.19.2 Product and Service Offerings
7.19.3 Key Financial Summary
7.20 Medela AG
7.20.1 Business Overview
7.20.2 Product and Service Offerings
7.21 Lohmann & Rauscher GmbH & Co. KG
7.21.1 Business Overview
7.21.2 Product and Service Offerings
7.22 Nitto Denko Corporation
7.22.1 Business Overview
7.22.2 Product and Service Offerings
7.22.3 Key Financial Summary
7.23 Weigao Group Co. Ltd.
7.23.1 Business Overview
7.23.2 Product and Service Offerings
7.23.3 Key Financial Summary
Chapter 8. Appendix
8.1 Abbreviations
8.2 Sources and References
8.3 Related Report
LIST OF TABLES
TABLE 1 ANALYSIS PERIOD OF THE STUDY
TABLE 2 DRIVERS FOR THE MARKET: IMPACT ANALYSIS
TABLE 3 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS
TABLE 4 PRICING OF SOME MAJORLY USED WOUND DRESSING PRODUCTS
TABLE 5 HONG KONG WOUND DRESSING MARKET, BY TYPE, $’000 (2015–2020)
TABLE 6 HONG KONG WOUND DRESSING MARKET, BY TYPE, $’000 (2021–2025)
TABLE 7 HONG KONG WOUND DRESSING MARKET, BY TYPE, $’000 (2026–2030)
TABLE 8 HONG KONG ADVANCED WOUND DRESSING MARKET, BY TYPE, $’000 (2015–2020)
TABLE 9 HONG KONG ADVANCED WOUND DRESSING MARKET, BY TYPE, $’000 (2021–2025)
TABLE 10 HONG KONG ADVANCED WOUND DRESSING MARKET, BY TYPE, $’000 (2026–2030)
TABLE 11 HONG KONG FOAM DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2015–2020)
TABLE 12 HONG KONG FOAM DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2021–2025)
TABLE 13 HONG KONG FOAM DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2026–2030)
TABLE 14 HONG KONG FOAM DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2015–2020)
TABLE 15 HONG KONG FOAM DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2021–2025)
TABLE 16 HONG KONG FOAM DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2026–2030)
TABLE 17 HONG KONG HYDROCOLLOID DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2015–2020)
TABLE 18 HONG KONG HYDROCOLLOID DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2021–2025)
TABLE 19 HONG KONG HYDROCOLLOID DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2026–2030)
TABLE 20 HONG KONG HYDROCOLLOID DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2015–2020)
TABLE 21 HONG KONG HYDROCOLLOID DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2021–2025)
TABLE 22 HONG KONG HYDROCOLLOID DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2026–2030)
TABLE 23 HONG KONG FILM DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2015–2020)
TABLE 24 HONG KONG FILM DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2021–2025)
TABLE 25 HONG KONG FILM DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2026–2030)
TABLE 26 HONG KONG FILM DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2015–2020)
TABLE 27 HONG KONG FILM DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2021–2025)
TABLE 28 HONG KONG FILM DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2026–2030)
TABLE 29 HONG KONG ALGINATE DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2015–2020)
TABLE 30 HONG KONG ALGINATE DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2021–2025)
TABLE 31 HONG KONG ALGINATE DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2026–2030)
TABLE 32 HONG KONG ALGINATE DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2015–2020)
TABLE 33 HONG KONG ALGINATE DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2021–2025)
TABLE 34 HONG KONG ALGINATE DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2026–2030)
TABLE 35 HONG KONG ANTIMICROBIAL DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2015–2020)
TABLE 36 HONG KONG ANTIMICROBIAL DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2021–2025)
TABLE 37 HONG KONG ANTIMICROBIAL DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2026–2030)
TABLE 38 HONG KONG ANTIMICROBIAL DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2015–2020)
TABLE 39 HONG KONG ANTIMICROBIAL DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2021–2025)
TABLE 40 HONG KONG ANTIMICROBIAL DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2026–2030)
TABLE 41 HONG KONG HYDROGEL DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2015–2020)
TABLE 42 HONG KONG HYDROGEL DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2021–2025)
TABLE 43 HONG KONG HYDROGEL DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2026–2030)
TABLE 44 HONG KONG HYDROGEL DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2015–2020)
TABLE 45 HONG KONG HYDROGEL DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2021–2025)
TABLE 46 HONG KONG HYDROGEL DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2026–2030)
TABLE 47 HONG KONG COLLAGEN DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2015–2020)
TABLE 48 HONG KONG COLLAGEN DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2021–2025)
TABLE 49 HONG KONG COLLAGEN DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2026–2030)
TABLE 50 HONG KONG COLLAGEN DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2015–2020)
TABLE 51 HONG KONG COLLAGEN DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2021–2025)
TABLE 52 HONG KONG COLLAGEN DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2026–2030)
TABLE 53 HONG KONG HYDROFIBER DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2015–2020)
TABLE 54 HONG KONG HYDROFIBER DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2021–2025)
TABLE 55 HONG KONG HYDROFIBER DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2026–2030)
TABLE 56 HONG KONG HYDROFIBER DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2015–2020)
TABLE 57 HONG KONG HYDROFIBER DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2021–2025)
TABLE 58 HONG KONG HYDROFIBER DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2026–2030)
TABLE 59 HONG KONG WOUND CONTACT LAYER DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2015–2020)
TABLE 60 HONG KONG WOUND CONTACT LAYER DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2021–2025)
TABLE 61 HONG KONG WOUND CONTACT LAYER DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2026–2030)
TABLE 62 HONG KONG WOUND CONTACT LAYER DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2015–2020)
TABLE 63 HONG KONG WOUND CONTACT LAYER DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2021–2025)
TABLE 64 HONG KONG WOUND CONTACT LAYER DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2026–2030)
TABLE 65 HONG KONG SUPERABSORBENT DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2015–2020)
TABLE 66 HONG KONG SUPERABSORBENT DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2021–2025)
TABLE 67 HONG KONG SUPERABSORBENT DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2026–2030)
TABLE 68 HONG KONG SUPERABSORBENT DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2015–2020)
TABLE 69 HONG KONG SUPERABSORBENT DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2021–2025)
TABLE 70 HONG KONG SUPERABSORBENT DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2026–2030)
TABLE 71 HONG KONG NPWT DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2015–2020)
TABLE 72 HONG KONG NPWT DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2021–2025)
TABLE 73 HONG KONG NPWT DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2026–2030)
TABLE 74 HONG KONG NPWT DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2015–2020)
TABLE 75 HONG KONG NPWT DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2021–2025)
TABLE 76 HONG KONG NPWT DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2026–2030)
TABLE 77 HONG KONG TRADITIONAL WOUND DRESSING MARKET, BY TYPE, $’000 (2015–2020)
TABLE 78 HONG KONG TRADITIONAL WOUND DRESSING MARKET, BY TYPE, $’000 (2021–2025)
TABLE 79 HONG KONG TRADITIONAL WOUND DRESSING MARKET, BY TYPE, UNITS (2026–2030)
TABLE 80 HONG KONG WOUND DRESSING MARKET, BY APPLICATION, $’000 (2015–2020)
TABLE 81 HONG KONG WOUND DRESSING MARKET, BY APPLICATION, $’000 (2021–2025)
TABLE 82 HONG KONG WOUND DRESSING MARKET, BY APPLICATION, $’000 (2026–2030)
TABLE 83 HONG KONG WOUND DRESSING MARKET FOR CHRONIC WOUNDS, BY TYPE, $’000 (2015–2020)
TABLE 84 HONG KONG WOUND DRESSING MARKET FOR CHRONIC WOUNDS, BY TYPE, $’000 (2021–2025)
TABLE 85 HONG KONG WOUND DRESSING MARKET FOR CHRONIC WOUNDS, BY TYPE, $’000 (2026–2030)
TABLE 86 HONG KONG WOUND DRESSING MARKET FOR ACUTE WOUNDS, BY TYPE, $’000 (2015–2020)
TABLE 87 HONG KONG WOUND DRESSING MARKET FOR ACUTE WOUNDS, BY TYPE, $’000 (2021–2025)
TABLE 88 HONG KONG WOUND DRESSING MARKET FOR ACUTE WOUNDS, BY TYPE, $’000 (2026–2030)
TABLE 89 HONG KONG WOUND DRESSING MARKET, BY END USER, $’000 (2015–2020)
TABLE 90 HONG KONG WOUND DRESSING MARKET, BY END USER, $’000 (2021–2025)
TABLE 91 HONG KONG WOUND DRESSING MARKET, BY END USER, $’000 (2026–2030)
TABLE 92 HONG KONG MARKET FOR WOUND DRESSINGS FOR HOSPITAL AND SPECIALTY CLINIC USE, BY TYPE, $’000 (2015–2020)
TABLE 93 HONG KONG MARKET FOR WOUND DRESSINGS FOR HOSPITAL AND SPECIALTY CLINIC USE, BY TYPE, $’000 (2021–2025)
TABLE 94 HONG KONG MARKET FOR WOUND DRESSINGS FOR HOSPITAL AND SPECIALTY CLINIC USE, BY TYPE, $’000 (2026–2030)
TABLE 95 HONG KONG WOUND DRESSING MARKET, BY DISTRIBUTION CHANNEL, $’000 (2015–2020)
TABLE 96 HONG KONG WOUND DRESSING MARKET, BY DISTRIBUTION CHANNEL, $’000 (2021–2025)
TABLE 97 HONG KONG WOUND DRESSING MARKET, BY DISTRIBUTION CHANNEL, $’000 (2026–2030)
TABLE 98 COLOPLAST A/S – AT A GLANCE
TABLE 99 COLOPLAST A/S – KEY FINANCIAL SUMMARY
TABLE 100 3M COMPANY – AT A GLANCE
TABLE 101 3M COMPANY – KEY FINANCIAL SUMMARY
TABLE 102 PAUL HARTMANN AG – AT A GLANCE
TABLE 103 PAUL HARTMANN AG – KEY FINANCIAL SUMMARY
TABLE 104 WINNER MEDICAL CO. LTD. – AT A GLANCE
TABLE 105 MÖLNLYCKE HEALTH CARE AB – AT A GLANCE
TABLE 106 MÖLNLYCKE HEALTH CARE AB – KEY FINANCIAL SUMMARY
TABLE 107 SMITH & NEPHEW PLC – AT A GLANCE
TABLE 108 SMITH & NEPHEW PLC – KEY FINANCIAL SUMMARY
TABLE 109 CONVATEC GROUP PLC – AT A GLANCE
TABLE 110 CONVATEC GROUP PLC – KEY FINANCIAL SUMMARY
TABLE 111 ALLMED MEDICAL PRODUCTS CO. LTD. – AT A GLANCE
TABLE 112 ZHENDE MEDICAL CO. LTD. – AT A GLANCE
TABLE 113 WAYSON MEDICAL CO. LTD. – AT A GLANCE
TABLE 114 B. BRAUN MELSUNGEN AG – AT A GLANCE
TABLE 115 B. BRAUN MELSUNGEN AG – KEY FINANCIAL SUMMARY
TABLE 116 ESSITY AB – AT A GLANCE
TABLE 117 ESSITY AB – KEY FINANCIAL SUMMARY
TABLE 118 BEIERSDORF AG – AT A GLANCE
TABLE 119 BEIERSDORF AG – KEY FINANCIAL SUMMARY
TABLE 120 JOHNSON & JOHNSON – AT A GLANCE
TABLE 121 JOHNSON & JOHNSON – KEY FINANCIAL SUMMARY
TABLE 122 URGO MEDICAL – AT A GLANCE
TABLE 123 CARDINAL HEALTH INC. – AT A GLANCE
TABLE 124 CARDINAL HEATH INC. – KEY FINANCIAL SUMMARY
TABLE 125 MEDTRONIC PLC – AT A GLANCE
TABLE 126 MEDTRONIC PLC – KEY FINANCIAL SUMMARY
TABLE 127 INTEGRA LIFESCIENCES HOLDINGS CORPORATION – AT A GLANCE
TABLE 128 INTEGRA LIFESCIENCES HOLDINGS CORPORATION – KEY FINANCIAL SUMMARY
TABLE 129 WRIGHT MEDICAL GROUP N.V. – AT A GLANCE
TABLE 130 WRIGHT MEDICAL GROUP N.V. – KEY FINANCIAL SUMMARY
TABLE 131 MEDELA AG – AT A GLANCE
TABLE 132 LOHMANN & RAUSCHER GMBH & CO. KG – AT A GLANCE
TABLE 133 NITTO DENKO CORPORATION – AT A GLANCE
TABLE 134 NITTO DENKO CORPORATION – KEY FINANCIAL SUMMARY
TABLE 135 WEIGAO GROUP CO. LTD. – AT A GLANCE
TABLE 136 WEIGAO GROUP CO., LTD. – KEY FINANCIAL SUMMARY
LIST OF FIGURES
FIG 1 RESEARCH SCOPE
FIG 2 RESEARCH METHODOLOGY
FIG 3 BREAKDOWN OF PRIMARY RESEARCH, BY INDUSTRY PARTICIPANT
FIG 4 BREAKDOWN OF PRIMARY RESEARCH, BY DESIGNATION
FIG 5 BREAKDOWN OF PRIMARY RESEARCH, BY COMPANY TYPE
FIG 6 DATA TRIANGULATION APPROACH
FIG 7 HONG KONG WOUND DRESSING MARKET SUMMARY
FIG 8 BARGAINING POWER OF BUYERS
FIG 9 BARGAINING POWER OF SUPPLIERS
FIG 10 INTENSITY OF RIVALRY
FIG 11 THREAT OF NEW ENTRANTS
FIG 12 THREAT OF SUBSTITUTES
FIG 13 HONG KONG WOUND DRESSING MARKET SNAPSHOT
FIG 14 HONG KONG WOUND DRESSING MARKET, BY TYPE, $’000 (2015–2030)
FIG 15 HONG KONG ADVANCED WOUND DRESSING MARKET, BY TYPE, $’000 (2015–2030)
FIG 16 HONG KONG TRADITIONAL WOUND DRESSING MARKET, BY TYPE, $’000 (2015–2030)
FIG 17 HONG KONG WOUND DRESSING MARKET, BY APPLICATION, $’000 (2015–2030)
FIG 18 HONG KONG WOUND DRESSING MARKET FOR CHRONIC WOUNDS, BY TYPE, $’000 (2015–2030)
FIG 19 HONG KONG WOUND DRESSING MARKET FOR ACUTE WOUNDS, BY TYPE, $’000 (2015–2030)
FIG 20 HONG KONG WOUND DRESSING MARKET, BY END USER, $’000 (2015–2030)
FIG 21 HONG KONG MARKET FOR WOUND DRESSINGS FOR HOSPITAL AND SPECIALTY CLINIC USE, BY TYPE, $’000 (2015–2030)
FIG 22 HONG KONG WOUND DRESSING MARKET, BY DISTRIBUTION CHANNEL, $’000 (2015–2030)
FIG 23 COLOPLAST A/S – REVENUE SPLIT BY BUSINESS AREA AND GEOGRAPHY (2020)
FIG 24 3M COMPANY – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2020)
FIG 25 PAUL HARTMANN AG – REVENUE SPLIT BY BUSINESS DIVISION AND GEOGRAPHY (2020)
FIG 26 MÖLNLYCKE HEALTH CARE AB – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2020)
FIG 27 SMITH & NEPHEW PLC – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2020)
FIG 28 CONVATEC GROUP PLC – REVENUE SPLIT BY FRANCHISE AND GEOGRAPHY (2020)
FIG 29 B. BRAUN MELSUNGEN AG – REVENUE SPLIT BY DIVISION AND GEOGRAPHY (2020)
FIG 30 ESSITY AB – REVENUE SPLIT BY BUSINESS AREA AND GEOGRAPHY (2020)
FIG 31 BEIERSDORF AG – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2020)
FIG 32 JOHNSON & JOHNSON – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2020)
FIG 33 CARDINAL HEALTH INC. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2020)
FIG 34 MEDTRONIC PLC – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2020)
FIG 35 INTEGRA LIFESCIENCES HOLDINGS CORPORATION – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2020)
FIG 36 WRIGHT MEDICAL GROUP N.V. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 37 NITTO DENKO CORPORATION – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2020)
FIG 38 WEIGAO GROUP CO., LTD. – REVENUE SPLIT BY PRINCIPAL PRODUCT AND GEOGRAPHY (2020)"
Note: Product cover images may vary from those shown
  • Coloplast A/S
  • 3M Company
  • Paul Hartmann AG
  • Winner Medical Co. Ltd.
  • Mölnlycke Health Care AB
  • Smith & Nephew plc
  • ConvaTec Group plc
  • Allmed Medical Products Co. Ltd.
  • Zhende Medical Co. Ltd.
  • Wayson Medical Co. Ltd.
  • B. Braun Melsungen AG
  • Essity AB
  • Beiersdorf AG
  • Johnson & Johnson
  • Urgo Medical
  • Cardinal Health Inc.
  • Medtronic plc
  • Integra LifeSciences Holdings Corporation
  • Wright Medical Group N.V.
  • Lohmann & Rauscher GmbH & Co. KG
  • Nitto Denko Corporation
  • Weigao Group Co. Ltd.
Note: Product cover images may vary from those shown

Loading
LOADING...